코스피

4,840.74

  • 43.19
  • 0.90%
코스닥

954.59

  • 3.43
  • 0.36%
1/3

[PRNewswire] Fluxergy Announces $30 Million to Expand Manufacturing Capacity

페이스북 노출 0

핀(구독)!


뉴스 듣기-

지금 보시는 뉴스를 읽어드립니다.

이동 통신망을 이용하여 음성을 재생하면 별도의 데이터 통화료가 부과될 수 있습니다.

[PRNewswire] Fluxergy Announces $30 Million to Expand Manufacturing Capacity

주요 기사

    글자 크기 설정

    번역-

    G언어 선택

    • 한국어
    • 영어
    • 일본어
    • 중국어(간체)
    • 중국어(번체)
    • 베트남어
    [PRNewswire] Fluxergy Announces $30 Million to Expand Manufacturing Capacity
    of Its One-hour Point-of-care Diagnostic Testing System in Response to COVID-19

    (IRVINE, California, May 13, 2020 PRNewswire=연합뉴스) Irvine, California-based Fluxergy LLC, a diagnostic test company, is making a $30 million investment to expand its capability to scale production of the Fluxergy Analyzer diagnostic testing system in response to the COVID-19 pandemic.


    The Fluxergy system, utilizing state-of-the-art PCR and microfluidics technology, has been shown to accurately identify the SARS-CoV-2 virus in one hour in studies conducted by the company, and by physician-scientists at the University of California San Diego. Fluxergy has started additional validation studies at world-leading health systems and plans to continue making its testing platform available as a Research Use Only (RUO) system for suitable partners during the current public health emergency.

    "We anticipate that our significant investment to step up our manufacturing capability will enable Fluxergy to deliver as many as one million tests per month by the end of 2020, reflecting our confidence in our technology as an innovative solution to COVID-19 testing shortages," said Dr. Ali Tinazli, Chief Commercial Officer of Fluxergy.


    Fluxergy recently filed a request for an Emergency Use Authorization (EUA) with the U.S. Food and Drug Administration (FDA) to permit medical sites with CLIA-certified high complexity laboratories to begin using the company's high-speed test system for COVID-19 in accordance with the scope of FDA's authorization.

    About Fluxergy
    Fluxergy, launched in 2013 with funding support of principal investor and Kingston Technology co-founder John Tu, seeks to provide a portable, easy to use sample-to-answer POC platform that enables clinicians to cost-effectively conduct a wide range of multiplex and multimodal in vitro diagnostic tests (different types of tests all at once, up to 30 targets). Visit fluxergy.com for more information.



    Photo - https://mma.prnewswire.com/media/1167640/FluxergyAnalyzerSystem.jpg
    The Fluxergy Analyzer System: single-use consumable Fluxergy Card, Fluxergy Analyzer, and its user interface Fluxergy

    Photo - https://mma.prnewswire.com/media/1167641/Fluxergy_Co_Founder_President.jpg
    Fluxergy's Co-Founder & President Tej Patel (left) and Investor & Co-Founder of Kingston Technologies, John Tu (right) with the Fluxergy Analyzer and Test Card.


    CONTACT: Dr. Ali Tinazli, atinazli@fluxergy.com +1 (310) 467-1112

    Source: Fluxergy


    [편집자 주] 본고는 자료 제공사에서 제공한 것으로, 연합뉴스는 내용에 대해 어떠한 편집도 하지 않았음을 밝혀 드립니다.
    (끝)

    <저작권자(c) 연합뉴스, 무단 전재-재배포 금지>



    - 염색되는 샴푸, 대나무수 화장품 뜬다

    실시간 관련뉴스